Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lentiviral vector containing the human MYO7A gene

EU orphan designation number: EU/3/10/727   
Active ingredient: Lentiviral vector containing the human MYO7A gene
Indication: Treatment of retinitis pigmentosa in Usher syndrome 1B
Sponsor: Sanofi-Aventis groupe
54 rue La Boétie, F-75008 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/03/2010 Orphan Designation EMEA/OD/137/09 (2010)2052 of 23/03/2010
23/06/2014 Transfer of orphan designation EMA/OD/137/09/T/01 (2014)4244 of 19/06/2014
09/06/2015 Transfer of orphan designation EMA/OD/137/09/T/02 (2015)3927 of 05/06/2015